Long intergenic non-protein coding RNA 1224 (LINC01224) drives the malignant progression of epithelial ovarian cancer (EOC) cells by modulating the microRNA-485-5p (miR-485-5p)/p21‑activated kinase 4 (PAK4) axis. (A and B) qRT-PCR and Western blotting were conducted to measure the expression levels of PAK4 mRNA and protein in Caov-3 and OVCAR3 cells after small interfering RNA targeting LINC01224 (si-LINC01224) or negative control small interfering RNA (si-NC) transfection. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as a loading control. (C) The knockdown efficiency of miR-485-5p inhibitor in Caov-3 and OVCAR3 cells was determined by qRT-PCR. Negative control (NC) inhibitor served as the control. (D and E) si-LINC01224, together with miR-485-5p inhibitor or NC inhibitor, was transfected into Caov-3 and OVCAR3 cells. The transfected cells were collected, and the mRNA and protein levels of PAK4 via qRT-PCR and Western blotting were measured. (F) The efficiency of pCDNA3.1-PAK4 (pc-PAK4) transfection was detected by Western blotting. The empty pcDNA3.1 vector served as the control. (G and H) LINC01224-depleted Caov-3 and OVCAR3 cells were co-transfected with miR-485-5p inhibitor or pc-PAK4. The CCK-8 assay and flow cytometry analysis were used to assess cell proliferation and apoptosis, respectively. PI, propidium iodide. (I and J) The migration and invasion of the cells mentioned above were detected via cell migration and invasion assays. *P < 0.05, **P < 0.01.